Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value?
Crane
Christopher H
CH
Thames
Howard D
HD
Hamilton
Stanley R
SR
D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000096:biosynthesis; D016158:Genes, p53; D006801:Humans; D019394:Ki-67 Antigen / Q000096:biosynthesis; D011379:Prognosis; D012004:Rectal Neoplasms / Q000378:metabolism / Q000628:therapy*
D014408:Biomarkers, Tumor; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D019394:Ki-67 Antigen